Pfizer, Inc. (PFE) Tops Q4 EPS by 3c; Guides In-Line
Pfizer, Inc. (NYSE: PFE) reported Q4 EPS of $0.47, $0.03 better than the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)